Vor Biopharma (VOR) Shareholder's Equity (2020 - 2026)

Vor Biopharma (VOR) Shareholder's Equity (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Vor Biopharma 627.54 Mn 627.54 Mn - -150.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -150.42 Mn
Dec 31, 2025 -164.31 Mn
Sep 30, 2025 -2.23 Bn
Jun 30, 2025 -1.51 Bn
Mar 31, 2025 66.07 Mn
Dec 31, 2024 -96.66 Mn
Sep 30, 2024 72.96 Mn
Jun 30, 2024 98.08 Mn
Mar 31, 2024 123.04 Mn
Dec 31, 2023 150.72 Mn
Sep 30, 2023 174.78 Mn
Jun 30, 2023 204.45 Mn
Mar 31, 2023 230.22 Mn
Dec 31, 2022 250.61 Mn
Sep 30, 2022 158.73 Mn
Jun 30, 2022 174.97 Mn
Mar 31, 2022 194.45 Mn
Dec 31, 2021 216.26 Mn
Sep 30, 2021 232.96 Mn
Jun 30, 2021 250.11 Mn